Hospira And Mochida Strike Marketing Alliance With Anti-Cancer Generic
This article was originally published in PharmAsia News
Executive Summary
Hospira Japan and Mochida Pharmaceuticals announced on Sept. 28 that they have signed a marketing alliance to enter the Japanese generic anti-cancer market.